CMPI - Checkmate Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $4.3. This is a potential upside of $4.3 (0%) from yesterday's end of day stock price of $0.

Checkmate Pharmaceuticals's activity chart (see below) currently has 3 price targets and 5 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 75% with an average time for these price targets to be met of 107 days.

Most recent stock forecast was given by KAVERI POHLMAN from BTIG on 19-Apr-2022. First documented stock forecast 31-Aug-2020.

Best performing analysts who are covering CMPI - Checkmate Pharmaceuticals:

Geoff Meacham Kaveri Pohlman

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$9

3 years 5 months 26 days ago
(19-Apr-2022)

1/1 (100%)

$5.78 (179.50%)

20

Buy

$7

$-3.5 (-33.33%)

$19

4 years 9 days ago
(06-Oct-2021)

1/2 (50%)

$2.82 (67.46%)

194

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CMPI (Checkmate Pharmaceuticals) average time for price targets to be met?

On average it took 107 days on average for the stock forecasts to be realized with a an average price target met ratio 75

Which analyst has the current highest performing score on CMPI (Checkmate Pharmaceuticals) with a proven track record?

GEOFF MEACHAM

Which analyst has the current lower performing score on CMPI (Checkmate Pharmaceuticals) with a proven track record?

KAVERI POHLMAN

Which analyst has the most public recommendations on CMPI (Checkmate Pharmaceuticals)?

Geoff Meacham works at CITI and has 14 price targets and 13 ratings on CMPI

Which analyst is the currently most bullish on CMPI (Checkmate Pharmaceuticals)?

Kaveri Pohlman with highest potential upside - $0

Which analyst is the currently most reserved on CMPI (Checkmate Pharmaceuticals)?

Geoff Meacham with lowest potential downside - -$3.5

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?